Case Studies on Vendor Oversight of Lab-Related Functions and CAPA Solutions
In today’s global clinical trial landscape, sponsors increasingly rely on vendors for managing complex laboratory functions. From central lab testing and biomarker analysis to sample logistics and data transfer, third-party vendors have become integral to operations. However, this reliance introduces significant regulatory risks if oversight mechanisms are not robust and compliant with FDA, EMA, and ICH GCP expectations.
Click to read the full article.